Dietary Supplement Innovation Act

Hemp-Derived Cannabidiol (CBD) regulations and legislation Regulatory enforcement of dietary supplements, Mandatory product registration issues H.R.7366, Dietary Supplement Regulatory Uniformity Act, Entirety H.R.7407, Prohibiting Tianeptine and Other Dangerous Products Act of 2026, Entirety H.R.10336, Dietary Supplement Innovation Act, Entirety

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to the prevention of the inclusion of illicit substances like tianeptine in dietary supplements. Mandatory product listing requirements for dietary supplements, including S. 3677 and H.R. 8370, the Dietary Supplement Listing Act of 2026. Issues related to P.L. 103-417, the Dietary Supplement Health and Education Act of 1994 drug preclusion provision, including H.R. 10336, the Dietary Supplement Innovation Act of 2026. Issues related to federal preemption of state requirements applicable to dietary supplements, including H.R. 7366, the Dietary Supplement Regulatory Uniformity Act. Issues related to the generally recognized as safe (GRAS) process. Issues related to FDA's "Simple Reform" reorganization and its impact on dietary supplement facility inspections and specialized inspectional expertise. General issues related to the dietary supplement industry.

Client expense: $70,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S.2292 - Over-the-Counter Monograph Drug User Fee Amendments H.R.4273 - Over-the-Counter Monograph Drug User Fee Amendments S.355 - FDA Modernization Act 3.0 H.R.2821 - FDA Modernization Act 3.0 H.R.3686 - SAFE Sunscreen Standards Act H.R.1 - One Big Beautiful Bill Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S.2491 - SAFE Sunscreen Standards Act H.R.6868 - ACCESS Through OTC Innovation Act S.2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches (SMART OTC Act) H.R.6868 - To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to apply the least burdensome appropriate means for supporting certain administrative order requests with respect to over-the-counter monograph drugs, and for other purposes. S.3122 - Better FDA Act of 2025 H.R.7366 - Dietary Supplement Regulatory Uniformity Act S.3788 - CLEAR LABELS Act - Activity related to Acetaminophen use - Nonprescription Drug Product with an Additional Condition for Nonprescription Use Rule H.R. 10336 - Dietary Supplement Innovation Act

Client expense: Not reported · Firm income: $146,407

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office